SightfileU.S. market data from official filings

AURINIA PHARMACEUTICALS INC (AUPH)

Name: AURINIA PHARMACEUTICALS INC (AUPH) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001600620 · EDGAR filings · Updated 2026-06-08

AURINIA PHARMACEUTICALS INC (AUPH) has reported institutional ownership of 55.6%, with 257 institutional managers holding positions valued at $1.09B per the latest 13F reporting period.

Institutional ownership

55.6%

Institutional managers

257

Reported 13F value

$1.09B

Insider activity

35 trans.

$26.1M net buying

Latest updates

2026-06-08 — Insider transaction reported (Form 4)
2026-06-08 — Insider transaction reported (Form 4)
2026-06-08 — Insider transaction reported (Form 4)
2026-06-08 — Insider transaction reported (Form 4)
2026-06-05 — Notice of proposed sale filed (Form 144)
2026-06-04 — SCHEDULE 13D/A filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, AURINIA PHARMACEUTICALS INC has 257 institutional holders and institutional ownership of 55.6%.

Insider activity

Insiders reported 35 transactions (9 buys, 1 sells) across 8 reporting insiders, with a net reported value of $26.1M.

Related companies

PHIBRO ANIMAL HEALTH CORP (PAHC) · SEPTERNA INC (SEPN) · ZENAS BIOPHARMA INC (ZBIO) · NOVOCURE LTD (NVCR) · IMMATICS N.V (IMTX) · RECURSION PHARMACEUTICALS IN (RXRX)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-08.